SlideShare a Scribd company logo
1 of 65
Download to read offline
Work-Up of Stillbirth
An Evidence Review




  Salah Roshdy,MD
  Professor of Obstetrics & Gynecology
  Qassim College of Medicine,KSA
  Sohag University , Egypt
Definitions
• Fetal death
  • Death prior to the complete expulsion of a product of
    human conception, irrespective of the duration of
    pregnancy .1

• Delivery of a fetus showing no signs of life
   • Absence of breathing, heart beat, umbilical cord
     pulsations, definitive voluntary movements




                       1National   Center for Health Statistics
Definition and Incidence
• Birth of a baby who shows no evidence of life
      • Heartbeat or breathing
• Definition varies from place to place
      • In Australia from 20w or 400g
      • WHO 500g- 22 w
      • In the UK from 24w
      • >350g in some states of US

• Rate varies from 5 per 1000 resource rich countries
  to 32 per 1000 in South Asia & Sub-Saharan Africa
Incidence
• > 3 million stillbirths each year worldwide
• 2007 rate of 6-7/1000 total births in US
• Rate of early stillbirth has remained stable
• Rate of late fetal loss has decreased by 29% since
  1990
• African Americans have 2x stillbirth rate as
  Caucasians
   •DM, HTN, abruption, PPROM
Types of Stillbirth

• Macerated stillbirth
     •Skin peeling implies that intrauterine
      fetal death has occurred >24 hours prior
      to delivery
• Fresh stillbirth
     •Implies that fetal death occurred after
      the onset of labour and is perhaps a
      reflection of intrapartum care
     •Better referred to as intrapartum death
Diagnosis of Stillbirth
• Absence of fetal movements is the usual symptom
• Diagnosis requires real-time ultrasound
      • Which should be available at all times
      • Diagnosis based on absence of fetal heart motion will
        be wrong up to 20% of the time
      • Both false positives and false negatives can occur
         • Scalp clip ECG is a dramatic example
• Some mothers feel passive fetal movements
      • So repeat ultrasound may be required
• May require colour Doppler in some cases
      • Severe oligohydramnios
      • Gross obesity
      • Spalding’s sign & intrafetal gas sometimes
Work-Up of Stillbirth
An Evidence Review
Etiology
• Unknown in 25 – 60% of cases
• Identifiable causes can be attributed to
  •Maternal conditions
  •Fetal conditions
  •Placental conditions
Maternal Conditions
• Prolonged pregnancy        • Eclampsia

• Diabetes (poorly controlled) • Hemoglobinopathy

• SLE                        • Rh disease

• APAS                       • Uterine rupture

• Infection                  • Maternal trauma or death

• HTN                        • Inherited thrombophilia

• Preeclampsia
Fetal conditions
• Multiple gestation
• IUGR
• Congenital anomaly
• Genetic abnormality
• Infection
• Hydrops
Placental Conditions
• Cord accident

• Abruption

• PROM

• Vasa previa

• Fetomaternal hemorrhage

• Placental insufficiency
Maternal Risk Factors
Developed Countries                      Developing Countries
                                         Obstructed prolonged labor and
Congenital and karyotypic anomalies
                                         associated asphyxia, infection, injury
                                         Infection – syphilis and gram-negative
Growth restriction/placental anomalies
                                         infection
Medical disease – diabetes, SLE, renal   Hypertensive disease – complications of
disease, thyroid, cholestasis            preeclampsia and eclampsia

Hypertensive disease, preeclampsia       Congenital anomalies

Infection – Parvovirus B19, syphilis,
                                         Poor nutritional status
GBS, listeria

Smoking                                  Malaria

Multiple gestation                       Sickle cell disease
Risk Factors in Developed Countries

• Non-Hispanic black race

• Nulliparity

• Advanced maternal age

• Obesity


                ACOG Practice Bulletin #102 March 2009
Most Frequent Types of Stillbirth According to GA

 24 - 27 weeks        28 - 37 weeks           37+ weeks
Infection (19%)     Unexplained (26%)      Unexplained (40%)


Abruptio placenta    Fetal malnutrition     Fetal malnutrition
     (14%)                 (19%)                  (14%)

Anomalies (14%)      Abruptio placenta      Abruptio placenta
                          (18%)                  (12%)


              Fretts and Usher. Contem Rev Ob Gyn 1997;9:173-9
Infection
• Most common cause of stillbirth 24 – 27 weeks
• Contribution to stillbirth rate is difficult to define
• Some pathogens are clearly causally related
   • Parvo B-19
   • CMV
   • Toxoplasmosis
• Some are associated with stillbirth but absent evidence of
  causal relationship
   • Ureaplasma urealyticum
   • Mycoplasma hominis
   • GBS
Infection
• Most stillbirths occur in premature fetuses
  • 19% of stillbirths < 28 weeks
  • 2% of stillbirths at term
• No change despite widespread use of antibiotics
• Viral pathogens are the most common source of
  hematogenous infection of the placenta
  • Fetal death resulting from maternal infection is rare
  • Diagnostic criteria are not well defined
Multiple Gestations
• 19.6 / 1,000 stillbirth rate (4x singletons)
• Complications specific to multiple gestations
  •TTTS
• Increased risk of common complications
• Placental abruption
  •Fetal anomalies
  •Growth restriction
  • PET         Cord accident
Advanced Maternal Age
• Lethal congenital and chromosomal anomalies
• Medical complications associated with age
  •Multiple gestations
  •HTN
  •DM
• Unexplained fetal demise is the only type that
  is statistically more common (late pregnancy)
Advanced Maternal Age
                                       Antepartum vs Intrapartum
                12

                                                                                             10.5
                10
                                                                                                9.3

                 8
Rate per 1000




                                                                             6.3                            Stillbirth
                 6
                                                                                   5.3                      Antepartum
                                                                                                            Intrapartum
                     4.4                                 4.4
                 4         3.6         3.6                     3.7
                                             3.2

                 2
                                                                                         1            1.2
                                 0.8               0.6               0.6
                 0
                     20 - 24            25 - 29          30 - 34              35 - 39          > 40

                                       Maternal age (yrs)
                                                                           Saliu et al. J Obstet Gynaecol 2008;34:843
Obesity (BMI ≥ 30)
• Increased risk
• Behavioral, socioeconomic and obstetric factors
  • Smoking, diabetes, preeclampsia
• Risk remains even after controlling for above
• Theories
  • Perception of fetal movements
  • Hyperlipidemia
  • Apnea – hypoxia events
Obesity

  BMI            Stillbirth Rate per 1000

  < 30                  5.5 / 1000

30 – 39.9                8 / 1000

  ≥ 40                  11 / 1000
Chromosomal Abnormalities
• Abnormal karyotype found in 8 – 13% stillbirths
   • > 20% with anatomic abnormalities or growth restriction
   • 4.6% with normally formed fetuses
• Most common abnormalities
   • Monosomy X (23%)
   • Trisomy 21 (23%)
   • Trisomy 18 (21%)
   • Trisomy 13 (8%)
• Karyotypic analysis underestimates risk
Chromosomal Abnormalities


Method                             Success Rate

Amniocentesis / CVS                    85%


Fetal tissue sampling                  28%



                        Korteweg et al 2008 Ob Gyn 111;865
Fetal Tissue
• Umbilical cord – 32.1%
• Fascia lata – 29.9%
• Cartilage – 24.2%
• Fetal blood – 22.2%
• Pericardium – 0%
• Other tissue – 19.2%
  •Placenta, skin, unknown
Chromosomal Abnormalities




          Korteweg et al 2008 Ob Gyn 111;865
Cord Accidents
• 30% of normal pregnancies
• Account for only 2.5% of stillbirths in autopsy
  case series
• Attribution requires
  •Cord occlusion and hypoxic tissue on autopsy
  •Exclusion of other causes
• Actual proportion remains uncertain
Thrombophilia
• Relationship with late fetal death is more consistent than
  with early losses
• Have been associated with late loss but lack of evidence
  of causal relationship
• Inconsistent studies
  • OR range from 1.8 to 12
• Thrombophilias are not uncommon
  • 15 – 25% of Caucasian populations
Thrombophilia
• Some but not all studies show a relationship with
  adverse outcomes
• Most are retrospective or case-controlled
  •Prospective longitudinal studies are needed
• Inappropriate or no controls
• No evaluation for other causes
• At least one type of thrombophilia is seen in 30%
  of normal controls
Thrombophilia




Gonen R et al. Absence of association of inherited thrombophilia
with unexplained third-trimester intrauterine fetal death. AJOG
2005;192:742-6
Types
• Wigglesworth classification
• Aberdeen
• ReCoDe
• Fetal neonatal classification
ReCoDe
• Relevant Condition at Death

• Advantage-this system reduces the proportion
  of stillbirths currently categorised as
  unexplained.
ReCoDe
Catergories


                         Group A-Fetus


                   Group B-Umbilical cord


                        Group C-Placenta


                   Group D-Amniotic fluid


                         Group E-Uterus


                         Group F-Mother


                       Group G-Intrapartum


                        Group H-Trauma


                       Group I-unclassified
Group A-Fetus

                                  Group A-Fetus


                                                           2.infection
1.lethal congenital abnormality                                2.1 acute
                                                                     2.2 chronic


      3.non-immune hydrops
                                                     4.isoimmunisation



                                                   5.fetomaternal haemorrhage




                                                  6.GROWTH RESTRICTION



                                                   7.FETAL GROWTH RESTRICTION
Group B-UMBILICAL CORD
 B-UMBILICAL CORD



                           1-PROPLAPSE



                    2-CONSTRICTING LOOP OR KNOT



                     3-VELAMENTOUS INSERTION




                             4-OTHER
Group C-PLACENTA

C-PLACENTA



             1-ABRUTIO



             2-PRAEVIA



             3-VASA PRAEAVI



             4-Other placental insuffiency



             5-Other
Group D-amniotic fluid
D-amniotic fluid



                   1-chorioamnionitis



                   2-oilgohydramnios



                   3-polyhrdramnios



                        4-other
Group E-Uterus

E-Uterus



                  1-rupture



             2-uterine anomalies



                   3-other
Group F-mother
Mother



                        1-diabetes



                   2-thyroid disorders



                 3-essential hypertension



           4-hypertensive diseases in pregnancy



           5-lupus or antiphospolipid syndrome



                      6-cholestasis



                      7-drug misuse



                         8-other
Group G-Intrapartum

G-Intrapartum



                 1-asphyxia



                2-Birth trauma
Group H-trauma

H-trauma



             1-External



            2-iatrogenic
Group I-unclassified

    I-unclassified


         1-no relevant
          condition
          identified

             2-no
         information
           available
Wigglesworth Classification

• Pathophysiological approach


• Category 1
   Congenital defect/malformation (lethal or severe):

   • Only lethal or potentially lethal congenital malformation should be included here.



• Category 2

Unexplained antepartum fetal death:
EXTENDED WIGGLESWORTH CLASSIFICATION


• Category 3’ Death from intrapartum ‘asphyxia’,
 ‘anoxia or ‘trauma’:


  •This category covers any baby who would have
   survived but for some catastrophe occurring
   during labour.
  •These babies will tend to be
      • normally formed, stillborn
      • or with poor Apgar scores,
        • possible meconium aspiration
        • or evidence of acidosis.
EXTENDED WIGGLESWORTH CLASSIFICATION



• Category 4 Immaturity:
 •This applies to live births only,
 •who subsequently die from
   •structural pulmonary immaturity,
   •surfactant deficiency,
   • intra ventricular haemorrhage,
   • or their late consequences - including chronic
    lung damage.
EXTENDED WIGGLESWORTH CLASSIFICATION



• Category 5 Infection:
  • This applies where there is clear microbiological evidence of
    infection that could have caused death
 e.g. maternal infection with
               G B S,
               rubella,
               parvovirus B19,
               syphilis etc
EXTENDED WIGGLESWORTH CLASSIFICATION


• :Category 6 Other specific causes
  • Use this if there is a specific recognisable
     • fetal,
     • neonatal or
     • paediatric condition not covered under the earlier categories.
         • Examples include:
            (1) fetal conditions; twin-to-twin transfusion and
               hydrops fetalis;
            (2) neonatal conditions;
           • pulmonary haemorrhage,
           • pulmonary hypoplasia

             (3) paediatric conditions;
                    malignancy
                    acute abdominal catastrophe ( volvulus )
EXTENDED WIGGLESWORTH CLASSIFICATION

• Category 7 :
• Accident or non-intra partum trauma:

• Category 8 :
• Sudden infant death, cause unknown:

• Category 9 :
• Unclassifiable: To be used as a last resort. Details must be
  given if this option is ticked
Evaluation
Evaluation
• Fetal autopsy
  • Single most useful test
• Examination of placenta, cord and membranes
• Karyotype evaluation
  • 8 – 13% of stillbirths
  • Comparative genomic hybridization
     • Useful when fetal cells cannot be cultured
Infection
• Autopsy and histologic evaluation of placenta,
  membranes, and cord provide best evidence of infectious
  etiology
• Value of routine cultures and serology is controversial
• Parvovirus serology
• Screening for syphilis
• TORCH titers questionable utility
• Placental culture problematic
   • Incidence in live birth is unknown
   • DNA test associated with false positives
Hematologic Etiology
• Fetal – maternal hemorrhage
  •Kleihauer-Betke test
  •Typically underestimates fetal cell count with
   large FMH
• Red cell alloimmunization
  •Indirect Coombs’ test
  •Autopsy and placenta assessment useful
Thrombophilia
• Routine testing is controversial
• Evidence to support limited testing
  •Evidence of placental insufficiency
    •IUGR
    •Placental infraction
  •Recurrent fetal loss
  •Personal or family history of thrombosis
Medical Complications
• Exclude clinically overt diabetes and thyroid
  dysfunction
  •GDM has stillbirth rate similar to normal
  •Subclinical thyroid disease has not been
   proven as cause of still birth
• Screening for subclinical disease is of unproven
  benefit
Ante partum Surveillance
• Little evidence-based data to guide testing with
  previous unexplained stillbirth
  •32 – 34 weeks
  •2 – 4 weeks before gestational age of
   previous still birth
• Most subsequent pregnancies have a favorable
  outcome
• Increased risk of iatrogenic prematurity
Antepartum Testing Protocol




                              Weeks et al.
Antepartum Testing Protocol
• Protocol may not be appropriate for all previous
  stillbirths
   •Nonrecurring conditions
       •Perinatal infection
       •Fetal anomalies
       •Maternal trauma
   •Stillbirths following OB complications that can
     recur but cannot be predicted
       •Abruption
       •Prolapse
       •Uterine rupture
ACOG Practice
  Management of Stillbirth      March 2009

• Little evidence-based data to guide antepartum
  surveillance with prior unexplained stillbirth

• Antepartum testing may be initiated at 32 – 34 weeks

• Associated with potential morbidity and costs

  •16.3% delivery at or before 39 weeks

  •1% delivery before 36 weeks
ACOG Practice
• Antenatal testing before 37 weeks gestation
  •1.5% rate of iatrogenic prematurity for
   intervention based on false-positive test
• Excess risk of infant mortality due to late
  preterm birth
  •8.8 / 1000 at 32 – 33 weeks gestation
  •3 / 1000 at 34 – 36 weeks gestation
Silver et al. Work-up of stillbirth: a review of the evidence. AJOG 2007;196:433-444.
Pregnancy after Stillbirth

• Early booking & careful dating
• Obstetric consultation
• Screen for gestational diabetes
• Monitor fetal growth if previous loss was associated
  with IUGR
• Large studies indicate an increased risk of stillbirth
  ≈12-fold independent of known recurrent causes
• Timing of delivery needs to take into account
      • Risks to the baby
      • Potential mode of delivery
      • The time of the previous fetal loss
      • The wishes of the patient
Prevention
• Early prenatal care   • Improve awareness and
                          management of
• Screen for
                          decreased fetal
  congenital              movement
  anomalies
                        • Individualize risk
• Optimize health,        assessment late in
  weight gain             pregnancy, include
• Reduce multiples        race, age, obesity,
                          parity on treating a
                          women when she is
                          “post-dates”
THANK   YOU

More Related Content

What's hot

Iron deficiency anaemia in pregnancy
Iron deficiency anaemia in pregnancyIron deficiency anaemia in pregnancy
Iron deficiency anaemia in pregnancyAboubakr Elnashar
 
Cervical ripening and the bishop score
Cervical ripening and the bishop scoreCervical ripening and the bishop score
Cervical ripening and the bishop scoreMudia Akpos
 
Pre-Eclampsia & Eclampsia
Pre-Eclampsia & EclampsiaPre-Eclampsia & Eclampsia
Pre-Eclampsia & Eclampsialimgengyan
 
Premature rupture of membranes (prom)
Premature rupture of membranes (prom)Premature rupture of membranes (prom)
Premature rupture of membranes (prom)raj kumar
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetenceAdil Muhammed
 
Management of Rh negative pregnancy
Management of Rh negative pregnancyManagement of Rh negative pregnancy
Management of Rh negative pregnancyChimezie Obi
 
Diabetes Mellitus in Pregnancy
Diabetes Mellitus in PregnancyDiabetes Mellitus in Pregnancy
Diabetes Mellitus in Pregnancymeducationdotnet
 
Chorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityChorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityAli Al-Shimmary
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean sectionhemnathsubedii
 
Hydatidiform (vesicular) mole
Hydatidiform (vesicular) moleHydatidiform (vesicular) mole
Hydatidiform (vesicular) moleraj kumar
 
BAD OBTETRIC HISTORY
BAD OBTETRIC HISTORYBAD OBTETRIC HISTORY
BAD OBTETRIC HISTORYYogesh Patel
 
Breech presentation
Breech presentationBreech presentation
Breech presentationraj kumar
 

What's hot (20)

Iron deficiency anaemia in pregnancy
Iron deficiency anaemia in pregnancyIron deficiency anaemia in pregnancy
Iron deficiency anaemia in pregnancy
 
Cervical ripening and the bishop score
Cervical ripening and the bishop scoreCervical ripening and the bishop score
Cervical ripening and the bishop score
 
Pre-Eclampsia & Eclampsia
Pre-Eclampsia & EclampsiaPre-Eclampsia & Eclampsia
Pre-Eclampsia & Eclampsia
 
Premature rupture of membranes (prom)
Premature rupture of membranes (prom)Premature rupture of membranes (prom)
Premature rupture of membranes (prom)
 
Fetal distress
Fetal distressFetal distress
Fetal distress
 
PROM
PROMPROM
PROM
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
HIV IN PREGNANCY
HIV IN PREGNANCYHIV IN PREGNANCY
HIV IN PREGNANCY
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
 
Management of Rh negative pregnancy
Management of Rh negative pregnancyManagement of Rh negative pregnancy
Management of Rh negative pregnancy
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 
Diabetes Mellitus in Pregnancy
Diabetes Mellitus in PregnancyDiabetes Mellitus in Pregnancy
Diabetes Mellitus in Pregnancy
 
Chorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityChorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain University
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean section
 
Incomplete abortion
Incomplete abortion Incomplete abortion
Incomplete abortion
 
pre eclampsia
pre eclampsiapre eclampsia
pre eclampsia
 
Hydatidiform (vesicular) mole
Hydatidiform (vesicular) moleHydatidiform (vesicular) mole
Hydatidiform (vesicular) mole
 
BAD OBTETRIC HISTORY
BAD OBTETRIC HISTORYBAD OBTETRIC HISTORY
BAD OBTETRIC HISTORY
 
Breech presentation
Breech presentationBreech presentation
Breech presentation
 
Asherman syndrome
Asherman syndromeAsherman syndrome
Asherman syndrome
 

Similar to Stillbirth prof.salah roshdy

Still Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainStill Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainLifecare Centre
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfSalahRoshdy2
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfSalahRoshdy2
 
Twin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.pptTwin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.pptSalahRoshdy2
 
MULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptxMULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptxMaryamYahya8
 
Cancer in pregnancy march 2012 ghatage co
Cancer in pregnancy march 2012 ghatage coCancer in pregnancy march 2012 ghatage co
Cancer in pregnancy march 2012 ghatage coTariq Mohammed
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women vandana bansal
 
Multiple Pregnancy September 2021
Multiple Pregnancy   September 2021Multiple Pregnancy   September 2021
Multiple Pregnancy September 2021OBGYN Notes
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy lossfaheta
 
Preterm Rupture of Membranes.ppt
Preterm Rupture of Membranes.pptPreterm Rupture of Membranes.ppt
Preterm Rupture of Membranes.pptSani42793
 
Dagan wells (1)
Dagan wells (1)Dagan wells (1)
Dagan wells (1)t7260678
 
Dagan wells
Dagan wellsDagan wells
Dagan wellst7260678
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptxRAHULSUTHAR46
 
9-Multiple pregnancy Dr. Fehmida Parveen.pptx
9-Multiple pregnancy Dr. Fehmida Parveen.pptx9-Multiple pregnancy Dr. Fehmida Parveen.pptx
9-Multiple pregnancy Dr. Fehmida Parveen.pptxMohammadTalha294621
 
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal DeathCare in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal DeathKervindran Mohanasundaram
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfJulioJulia3
 

Similar to Stillbirth prof.salah roshdy (20)

Still Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainStill Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda Jain
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
 
Multiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdfMultiple Pregnancy.Prof.Salah.pdf
Multiple Pregnancy.Prof.Salah.pdf
 
Lecture 10 Multifetal pregnancy
Lecture 10 Multifetal pregnancyLecture 10 Multifetal pregnancy
Lecture 10 Multifetal pregnancy
 
Twin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.pptTwin, Prof S.Roshdy.ppt
Twin, Prof S.Roshdy.ppt
 
MULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptxMULTIPLE PREGNANCY revision 2.pptx
MULTIPLE PREGNANCY revision 2.pptx
 
Twins
TwinsTwins
Twins
 
Cancer in pregnancy march 2012 ghatage co
Cancer in pregnancy march 2012 ghatage coCancer in pregnancy march 2012 ghatage co
Cancer in pregnancy march 2012 ghatage co
 
Stillbirth
StillbirthStillbirth
Stillbirth
 
Prevention of cancer in women
Prevention of cancer in women Prevention of cancer in women
Prevention of cancer in women
 
Multiple Pregnancy September 2021
Multiple Pregnancy   September 2021Multiple Pregnancy   September 2021
Multiple Pregnancy September 2021
 
Recurrent pregnancy loss
Recurrent pregnancy lossRecurrent pregnancy loss
Recurrent pregnancy loss
 
Preterm Rupture of Membranes.ppt
Preterm Rupture of Membranes.pptPreterm Rupture of Membranes.ppt
Preterm Rupture of Membranes.ppt
 
Multiple pregnancy.prof.salah
Multiple pregnancy.prof.salahMultiple pregnancy.prof.salah
Multiple pregnancy.prof.salah
 
Dagan wells (1)
Dagan wells (1)Dagan wells (1)
Dagan wells (1)
 
Dagan wells
Dagan wellsDagan wells
Dagan wells
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptx
 
9-Multiple pregnancy Dr. Fehmida Parveen.pptx
9-Multiple pregnancy Dr. Fehmida Parveen.pptx9-Multiple pregnancy Dr. Fehmida Parveen.pptx
9-Multiple pregnancy Dr. Fehmida Parveen.pptx
 
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal DeathCare in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
 

More from Salah Roshdy AHMED

New frontiers in endometriosis.Prof Salah.Roshdy
New frontiers in endometriosis.Prof Salah.RoshdyNew frontiers in endometriosis.Prof Salah.Roshdy
New frontiers in endometriosis.Prof Salah.RoshdySalah Roshdy AHMED
 
Recent guidline for management of HDP.Prof Salah Roshdy
Recent guidline for management of HDP.Prof Salah RoshdyRecent guidline for management of HDP.Prof Salah Roshdy
Recent guidline for management of HDP.Prof Salah RoshdySalah Roshdy AHMED
 
Madical treatment of ectopic pregnancy .Prof. Salah Roshdy
Madical treatment of ectopic  pregnancy .Prof. Salah RoshdyMadical treatment of ectopic  pregnancy .Prof. Salah Roshdy
Madical treatment of ectopic pregnancy .Prof. Salah RoshdySalah Roshdy AHMED
 
Organ transplantation.Prof S. Roshdy
Organ transplantation.Prof S. RoshdyOrgan transplantation.Prof S. Roshdy
Organ transplantation.Prof S. RoshdySalah Roshdy AHMED
 
Basic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.RoshdyBasic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.RoshdySalah Roshdy AHMED
 
Placenta accreta .Prof.S. Roshdy
Placenta accreta .Prof.S. RoshdyPlacenta accreta .Prof.S. Roshdy
Placenta accreta .Prof.S. RoshdySalah Roshdy AHMED
 
Kisspeptin,prof.Salah Roshdy modified
Kisspeptin,prof.Salah Roshdy modifiedKisspeptin,prof.Salah Roshdy modified
Kisspeptin,prof.Salah Roshdy modifiedSalah Roshdy AHMED
 
Female infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdyFemale infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdySalah Roshdy AHMED
 
Placenta & Fetal membrane.Prof.Salah Roshdy
Placenta & Fetal membrane.Prof.Salah RoshdyPlacenta & Fetal membrane.Prof.Salah Roshdy
Placenta & Fetal membrane.Prof.Salah RoshdySalah Roshdy AHMED
 
Evidence Based Management of Endometrioma
Evidence Based Management of EndometriomaEvidence Based Management of Endometrioma
Evidence Based Management of EndometriomaSalah Roshdy AHMED
 
H1N1 & Pregnancy.Prof Salah Roshdy
H1N1 & Pregnancy.Prof Salah Roshdy  H1N1 & Pregnancy.Prof Salah Roshdy
H1N1 & Pregnancy.Prof Salah Roshdy Salah Roshdy AHMED
 
Methotrexate in ectopic pregnancy prof.salah roshdy
Methotrexate in ectopic pregnancy prof.salah roshdyMethotrexate in ectopic pregnancy prof.salah roshdy
Methotrexate in ectopic pregnancy prof.salah roshdySalah Roshdy AHMED
 
Puerperium normal & abnormal prof.salah roshdy
Puerperium normal & abnormal prof.salah roshdyPuerperium normal & abnormal prof.salah roshdy
Puerperium normal & abnormal prof.salah roshdySalah Roshdy AHMED
 
Amniotic fluid disorder prof.salah
Amniotic fluid disorder prof.salahAmniotic fluid disorder prof.salah
Amniotic fluid disorder prof.salahSalah Roshdy AHMED
 
Pelvic endometrioma.prof.salah
Pelvic endometrioma.prof.salahPelvic endometrioma.prof.salah
Pelvic endometrioma.prof.salahSalah Roshdy AHMED
 
Management of the critically ill obstetric patient.prof.salah
Management of the critically ill obstetric patient.prof.salahManagement of the critically ill obstetric patient.prof.salah
Management of the critically ill obstetric patient.prof.salahSalah Roshdy AHMED
 

More from Salah Roshdy AHMED (20)

New frontiers in endometriosis.Prof Salah.Roshdy
New frontiers in endometriosis.Prof Salah.RoshdyNew frontiers in endometriosis.Prof Salah.Roshdy
New frontiers in endometriosis.Prof Salah.Roshdy
 
Recent guidline for management of HDP.Prof Salah Roshdy
Recent guidline for management of HDP.Prof Salah RoshdyRecent guidline for management of HDP.Prof Salah Roshdy
Recent guidline for management of HDP.Prof Salah Roshdy
 
Madical treatment of ectopic pregnancy .Prof. Salah Roshdy
Madical treatment of ectopic  pregnancy .Prof. Salah RoshdyMadical treatment of ectopic  pregnancy .Prof. Salah Roshdy
Madical treatment of ectopic pregnancy .Prof. Salah Roshdy
 
Organ transplantation.Prof S. Roshdy
Organ transplantation.Prof S. RoshdyOrgan transplantation.Prof S. Roshdy
Organ transplantation.Prof S. Roshdy
 
Basic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.RoshdyBasic infertility inves,Prof.S.Roshdy
Basic infertility inves,Prof.S.Roshdy
 
Placenta accreta .Prof.S. Roshdy
Placenta accreta .Prof.S. RoshdyPlacenta accreta .Prof.S. Roshdy
Placenta accreta .Prof.S. Roshdy
 
Aub prof.Salah Roshdy@
Aub prof.Salah Roshdy@Aub prof.Salah Roshdy@
Aub prof.Salah Roshdy@
 
Kisspeptin,prof.Salah Roshdy modified
Kisspeptin,prof.Salah Roshdy modifiedKisspeptin,prof.Salah Roshdy modified
Kisspeptin,prof.Salah Roshdy modified
 
Female infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah RoshdyFemale infertility,Prof.Salah Roshdy
Female infertility,Prof.Salah Roshdy
 
Placenta & Fetal membrane.Prof.Salah Roshdy
Placenta & Fetal membrane.Prof.Salah RoshdyPlacenta & Fetal membrane.Prof.Salah Roshdy
Placenta & Fetal membrane.Prof.Salah Roshdy
 
Evidence Based Management of Endometrioma
Evidence Based Management of EndometriomaEvidence Based Management of Endometrioma
Evidence Based Management of Endometrioma
 
AUB.Prof.Salah Roshdy
AUB.Prof.Salah RoshdyAUB.Prof.Salah Roshdy
AUB.Prof.Salah Roshdy
 
H1N1 & Pregnancy.Prof Salah Roshdy
H1N1 & Pregnancy.Prof Salah Roshdy  H1N1 & Pregnancy.Prof Salah Roshdy
H1N1 & Pregnancy.Prof Salah Roshdy
 
Benign ovarian tumors
Benign ovarian tumorsBenign ovarian tumors
Benign ovarian tumors
 
Methotrexate in ectopic pregnancy prof.salah roshdy
Methotrexate in ectopic pregnancy prof.salah roshdyMethotrexate in ectopic pregnancy prof.salah roshdy
Methotrexate in ectopic pregnancy prof.salah roshdy
 
Puerperium normal & abnormal prof.salah roshdy
Puerperium normal & abnormal prof.salah roshdyPuerperium normal & abnormal prof.salah roshdy
Puerperium normal & abnormal prof.salah roshdy
 
Amniotic fluid disorder prof.salah
Amniotic fluid disorder prof.salahAmniotic fluid disorder prof.salah
Amniotic fluid disorder prof.salah
 
Atypical pet prof.salah 1
Atypical pet prof.salah 1Atypical pet prof.salah 1
Atypical pet prof.salah 1
 
Pelvic endometrioma.prof.salah
Pelvic endometrioma.prof.salahPelvic endometrioma.prof.salah
Pelvic endometrioma.prof.salah
 
Management of the critically ill obstetric patient.prof.salah
Management of the critically ill obstetric patient.prof.salahManagement of the critically ill obstetric patient.prof.salah
Management of the critically ill obstetric patient.prof.salah
 

Stillbirth prof.salah roshdy

  • 1. Work-Up of Stillbirth An Evidence Review Salah Roshdy,MD Professor of Obstetrics & Gynecology Qassim College of Medicine,KSA Sohag University , Egypt
  • 2. Definitions • Fetal death • Death prior to the complete expulsion of a product of human conception, irrespective of the duration of pregnancy .1 • Delivery of a fetus showing no signs of life • Absence of breathing, heart beat, umbilical cord pulsations, definitive voluntary movements 1National Center for Health Statistics
  • 3. Definition and Incidence • Birth of a baby who shows no evidence of life • Heartbeat or breathing • Definition varies from place to place • In Australia from 20w or 400g • WHO 500g- 22 w • In the UK from 24w • >350g in some states of US • Rate varies from 5 per 1000 resource rich countries to 32 per 1000 in South Asia & Sub-Saharan Africa
  • 4. Incidence • > 3 million stillbirths each year worldwide • 2007 rate of 6-7/1000 total births in US • Rate of early stillbirth has remained stable • Rate of late fetal loss has decreased by 29% since 1990 • African Americans have 2x stillbirth rate as Caucasians •DM, HTN, abruption, PPROM
  • 5. Types of Stillbirth • Macerated stillbirth •Skin peeling implies that intrauterine fetal death has occurred >24 hours prior to delivery • Fresh stillbirth •Implies that fetal death occurred after the onset of labour and is perhaps a reflection of intrapartum care •Better referred to as intrapartum death
  • 6. Diagnosis of Stillbirth • Absence of fetal movements is the usual symptom • Diagnosis requires real-time ultrasound • Which should be available at all times • Diagnosis based on absence of fetal heart motion will be wrong up to 20% of the time • Both false positives and false negatives can occur • Scalp clip ECG is a dramatic example • Some mothers feel passive fetal movements • So repeat ultrasound may be required • May require colour Doppler in some cases • Severe oligohydramnios • Gross obesity • Spalding’s sign & intrafetal gas sometimes
  • 7. Work-Up of Stillbirth An Evidence Review
  • 8. Etiology • Unknown in 25 – 60% of cases • Identifiable causes can be attributed to •Maternal conditions •Fetal conditions •Placental conditions
  • 9. Maternal Conditions • Prolonged pregnancy • Eclampsia • Diabetes (poorly controlled) • Hemoglobinopathy • SLE • Rh disease • APAS • Uterine rupture • Infection • Maternal trauma or death • HTN • Inherited thrombophilia • Preeclampsia
  • 10. Fetal conditions • Multiple gestation • IUGR • Congenital anomaly • Genetic abnormality • Infection • Hydrops
  • 11. Placental Conditions • Cord accident • Abruption • PROM • Vasa previa • Fetomaternal hemorrhage • Placental insufficiency
  • 12.
  • 13. Maternal Risk Factors Developed Countries Developing Countries Obstructed prolonged labor and Congenital and karyotypic anomalies associated asphyxia, infection, injury Infection – syphilis and gram-negative Growth restriction/placental anomalies infection Medical disease – diabetes, SLE, renal Hypertensive disease – complications of disease, thyroid, cholestasis preeclampsia and eclampsia Hypertensive disease, preeclampsia Congenital anomalies Infection – Parvovirus B19, syphilis, Poor nutritional status GBS, listeria Smoking Malaria Multiple gestation Sickle cell disease
  • 14. Risk Factors in Developed Countries • Non-Hispanic black race • Nulliparity • Advanced maternal age • Obesity ACOG Practice Bulletin #102 March 2009
  • 15. Most Frequent Types of Stillbirth According to GA 24 - 27 weeks 28 - 37 weeks 37+ weeks Infection (19%) Unexplained (26%) Unexplained (40%) Abruptio placenta Fetal malnutrition Fetal malnutrition (14%) (19%) (14%) Anomalies (14%) Abruptio placenta Abruptio placenta (18%) (12%) Fretts and Usher. Contem Rev Ob Gyn 1997;9:173-9
  • 16. Infection • Most common cause of stillbirth 24 – 27 weeks • Contribution to stillbirth rate is difficult to define • Some pathogens are clearly causally related • Parvo B-19 • CMV • Toxoplasmosis • Some are associated with stillbirth but absent evidence of causal relationship • Ureaplasma urealyticum • Mycoplasma hominis • GBS
  • 17. Infection • Most stillbirths occur in premature fetuses • 19% of stillbirths < 28 weeks • 2% of stillbirths at term • No change despite widespread use of antibiotics • Viral pathogens are the most common source of hematogenous infection of the placenta • Fetal death resulting from maternal infection is rare • Diagnostic criteria are not well defined
  • 18. Multiple Gestations • 19.6 / 1,000 stillbirth rate (4x singletons) • Complications specific to multiple gestations •TTTS • Increased risk of common complications • Placental abruption •Fetal anomalies •Growth restriction • PET Cord accident
  • 19. Advanced Maternal Age • Lethal congenital and chromosomal anomalies • Medical complications associated with age •Multiple gestations •HTN •DM • Unexplained fetal demise is the only type that is statistically more common (late pregnancy)
  • 20. Advanced Maternal Age Antepartum vs Intrapartum 12 10.5 10 9.3 8 Rate per 1000 6.3 Stillbirth 6 5.3 Antepartum Intrapartum 4.4 4.4 4 3.6 3.6 3.7 3.2 2 1 1.2 0.8 0.6 0.6 0 20 - 24 25 - 29 30 - 34 35 - 39 > 40 Maternal age (yrs) Saliu et al. J Obstet Gynaecol 2008;34:843
  • 21. Obesity (BMI ≥ 30) • Increased risk • Behavioral, socioeconomic and obstetric factors • Smoking, diabetes, preeclampsia • Risk remains even after controlling for above • Theories • Perception of fetal movements • Hyperlipidemia • Apnea – hypoxia events
  • 22. Obesity BMI Stillbirth Rate per 1000 < 30 5.5 / 1000 30 – 39.9 8 / 1000 ≥ 40 11 / 1000
  • 23. Chromosomal Abnormalities • Abnormal karyotype found in 8 – 13% stillbirths • > 20% with anatomic abnormalities or growth restriction • 4.6% with normally formed fetuses • Most common abnormalities • Monosomy X (23%) • Trisomy 21 (23%) • Trisomy 18 (21%) • Trisomy 13 (8%) • Karyotypic analysis underestimates risk
  • 24. Chromosomal Abnormalities Method Success Rate Amniocentesis / CVS 85% Fetal tissue sampling 28% Korteweg et al 2008 Ob Gyn 111;865
  • 25. Fetal Tissue • Umbilical cord – 32.1% • Fascia lata – 29.9% • Cartilage – 24.2% • Fetal blood – 22.2% • Pericardium – 0% • Other tissue – 19.2% •Placenta, skin, unknown
  • 26. Chromosomal Abnormalities Korteweg et al 2008 Ob Gyn 111;865
  • 27. Cord Accidents • 30% of normal pregnancies • Account for only 2.5% of stillbirths in autopsy case series • Attribution requires •Cord occlusion and hypoxic tissue on autopsy •Exclusion of other causes • Actual proportion remains uncertain
  • 28. Thrombophilia • Relationship with late fetal death is more consistent than with early losses • Have been associated with late loss but lack of evidence of causal relationship • Inconsistent studies • OR range from 1.8 to 12 • Thrombophilias are not uncommon • 15 – 25% of Caucasian populations
  • 29. Thrombophilia • Some but not all studies show a relationship with adverse outcomes • Most are retrospective or case-controlled •Prospective longitudinal studies are needed • Inappropriate or no controls • No evaluation for other causes • At least one type of thrombophilia is seen in 30% of normal controls
  • 30. Thrombophilia Gonen R et al. Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death. AJOG 2005;192:742-6
  • 31.
  • 32. Types • Wigglesworth classification • Aberdeen • ReCoDe • Fetal neonatal classification
  • 33. ReCoDe • Relevant Condition at Death • Advantage-this system reduces the proportion of stillbirths currently categorised as unexplained.
  • 34. ReCoDe Catergories Group A-Fetus Group B-Umbilical cord Group C-Placenta Group D-Amniotic fluid Group E-Uterus Group F-Mother Group G-Intrapartum Group H-Trauma Group I-unclassified
  • 35. Group A-Fetus Group A-Fetus 2.infection 1.lethal congenital abnormality 2.1 acute 2.2 chronic 3.non-immune hydrops 4.isoimmunisation 5.fetomaternal haemorrhage 6.GROWTH RESTRICTION 7.FETAL GROWTH RESTRICTION
  • 36. Group B-UMBILICAL CORD B-UMBILICAL CORD 1-PROPLAPSE 2-CONSTRICTING LOOP OR KNOT 3-VELAMENTOUS INSERTION 4-OTHER
  • 37. Group C-PLACENTA C-PLACENTA 1-ABRUTIO 2-PRAEVIA 3-VASA PRAEAVI 4-Other placental insuffiency 5-Other
  • 38. Group D-amniotic fluid D-amniotic fluid 1-chorioamnionitis 2-oilgohydramnios 3-polyhrdramnios 4-other
  • 39. Group E-Uterus E-Uterus 1-rupture 2-uterine anomalies 3-other
  • 40. Group F-mother Mother 1-diabetes 2-thyroid disorders 3-essential hypertension 4-hypertensive diseases in pregnancy 5-lupus or antiphospolipid syndrome 6-cholestasis 7-drug misuse 8-other
  • 41. Group G-Intrapartum G-Intrapartum 1-asphyxia 2-Birth trauma
  • 42. Group H-trauma H-trauma 1-External 2-iatrogenic
  • 43. Group I-unclassified I-unclassified 1-no relevant condition identified 2-no information available
  • 44. Wigglesworth Classification • Pathophysiological approach • Category 1 Congenital defect/malformation (lethal or severe): • Only lethal or potentially lethal congenital malformation should be included here. • Category 2 Unexplained antepartum fetal death:
  • 45. EXTENDED WIGGLESWORTH CLASSIFICATION • Category 3’ Death from intrapartum ‘asphyxia’, ‘anoxia or ‘trauma’: •This category covers any baby who would have survived but for some catastrophe occurring during labour. •These babies will tend to be • normally formed, stillborn • or with poor Apgar scores, • possible meconium aspiration • or evidence of acidosis.
  • 46. EXTENDED WIGGLESWORTH CLASSIFICATION • Category 4 Immaturity: •This applies to live births only, •who subsequently die from •structural pulmonary immaturity, •surfactant deficiency, • intra ventricular haemorrhage, • or their late consequences - including chronic lung damage.
  • 47. EXTENDED WIGGLESWORTH CLASSIFICATION • Category 5 Infection: • This applies where there is clear microbiological evidence of infection that could have caused death e.g. maternal infection with G B S, rubella, parvovirus B19, syphilis etc
  • 48. EXTENDED WIGGLESWORTH CLASSIFICATION • :Category 6 Other specific causes • Use this if there is a specific recognisable • fetal, • neonatal or • paediatric condition not covered under the earlier categories. • Examples include: (1) fetal conditions; twin-to-twin transfusion and hydrops fetalis; (2) neonatal conditions; • pulmonary haemorrhage, • pulmonary hypoplasia (3) paediatric conditions; malignancy acute abdominal catastrophe ( volvulus )
  • 49. EXTENDED WIGGLESWORTH CLASSIFICATION • Category 7 : • Accident or non-intra partum trauma: • Category 8 : • Sudden infant death, cause unknown: • Category 9 : • Unclassifiable: To be used as a last resort. Details must be given if this option is ticked
  • 51. Evaluation • Fetal autopsy • Single most useful test • Examination of placenta, cord and membranes • Karyotype evaluation • 8 – 13% of stillbirths • Comparative genomic hybridization • Useful when fetal cells cannot be cultured
  • 52. Infection • Autopsy and histologic evaluation of placenta, membranes, and cord provide best evidence of infectious etiology • Value of routine cultures and serology is controversial • Parvovirus serology • Screening for syphilis • TORCH titers questionable utility • Placental culture problematic • Incidence in live birth is unknown • DNA test associated with false positives
  • 53. Hematologic Etiology • Fetal – maternal hemorrhage •Kleihauer-Betke test •Typically underestimates fetal cell count with large FMH • Red cell alloimmunization •Indirect Coombs’ test •Autopsy and placenta assessment useful
  • 54. Thrombophilia • Routine testing is controversial • Evidence to support limited testing •Evidence of placental insufficiency •IUGR •Placental infraction •Recurrent fetal loss •Personal or family history of thrombosis
  • 55. Medical Complications • Exclude clinically overt diabetes and thyroid dysfunction •GDM has stillbirth rate similar to normal •Subclinical thyroid disease has not been proven as cause of still birth • Screening for subclinical disease is of unproven benefit
  • 56. Ante partum Surveillance • Little evidence-based data to guide testing with previous unexplained stillbirth •32 – 34 weeks •2 – 4 weeks before gestational age of previous still birth • Most subsequent pregnancies have a favorable outcome • Increased risk of iatrogenic prematurity
  • 58. Antepartum Testing Protocol • Protocol may not be appropriate for all previous stillbirths •Nonrecurring conditions •Perinatal infection •Fetal anomalies •Maternal trauma •Stillbirths following OB complications that can recur but cannot be predicted •Abruption •Prolapse •Uterine rupture
  • 59. ACOG Practice Management of Stillbirth March 2009 • Little evidence-based data to guide antepartum surveillance with prior unexplained stillbirth • Antepartum testing may be initiated at 32 – 34 weeks • Associated with potential morbidity and costs •16.3% delivery at or before 39 weeks •1% delivery before 36 weeks
  • 60. ACOG Practice • Antenatal testing before 37 weeks gestation •1.5% rate of iatrogenic prematurity for intervention based on false-positive test • Excess risk of infant mortality due to late preterm birth •8.8 / 1000 at 32 – 33 weeks gestation •3 / 1000 at 34 – 36 weeks gestation
  • 61.
  • 62. Silver et al. Work-up of stillbirth: a review of the evidence. AJOG 2007;196:433-444.
  • 63. Pregnancy after Stillbirth • Early booking & careful dating • Obstetric consultation • Screen for gestational diabetes • Monitor fetal growth if previous loss was associated with IUGR • Large studies indicate an increased risk of stillbirth ≈12-fold independent of known recurrent causes • Timing of delivery needs to take into account • Risks to the baby • Potential mode of delivery • The time of the previous fetal loss • The wishes of the patient
  • 64. Prevention • Early prenatal care • Improve awareness and management of • Screen for decreased fetal congenital movement anomalies • Individualize risk • Optimize health, assessment late in weight gain pregnancy, include • Reduce multiples race, age, obesity, parity on treating a women when she is “post-dates”
  • 65. THANK YOU